228 related articles for article (PubMed ID: 18338108)
1. Erythropoietin in heart and vessels: focus on transcription and signalling pathways.
Marzo F; Lavorgna A; Coluzzi G; Santucci E; Tarantino F; Rio T; Conti E; Autore C; Agati L; Andreotti F
J Thromb Thrombolysis; 2008 Dec; 26(3):183-7. PubMed ID: 18338108
[TBL] [Abstract][Full Text] [Related]
2. Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice.
Satoh K; Kagaya Y; Nakano M; Ito Y; Ohta J; Tada H; Karibe A; Minegishi N; Suzuki N; Yamamoto M; Ono M; Watanabe J; Shirato K; Ishii N; Sugamura K; Shimokawa H
Circulation; 2006 Mar; 113(11):1442-50. PubMed ID: 16534010
[TBL] [Abstract][Full Text] [Related]
3. The molecular biology of erythropoietin.
Lacombe C; Mayeux P
Nephrol Dial Transplant; 1999; 14 Suppl 2():22-8. PubMed ID: 10334664
[TBL] [Abstract][Full Text] [Related]
4. Biology of erythropoietin.
Lacombe C; Mayeux P
Haematologica; 1998 Aug; 83(8):724-32. PubMed ID: 9793257
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells.
Beleslin-Cokic BB; Cokic VP; Yu X; Weksler BB; Schechter AN; Noguchi CT
Blood; 2004 Oct; 104(7):2073-80. PubMed ID: 15205261
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades.
Digicaylioglu M; Lipton SA
Nature; 2001 Aug; 412(6847):641-7. PubMed ID: 11493922
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin: physiology and pharmacology update.
Fisher JW
Exp Biol Med (Maywood); 2003 Jan; 228(1):1-14. PubMed ID: 12524467
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin-mediated protection of insect brain neurons involves JAK and STAT but not PI3K transduction pathways.
Miljus N; Heibeck S; Jarrar M; Micke M; Ostrowski D; Ehrenreich H; Heinrich R
Neuroscience; 2014 Jan; 258():218-27. PubMed ID: 24269933
[TBL] [Abstract][Full Text] [Related]
9. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
Landau D; London L; Bandach I; Segev Y
PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
[TBL] [Abstract][Full Text] [Related]
10. STAT5 as a Key Protein of Erythropoietin Signalization.
Tóthová Z; Tomc J; Debeljak N; Solár P
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281163
[TBL] [Abstract][Full Text] [Related]
11. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase.
Su KH; Shyue SK; Kou YR; Ching LC; Chiang AN; Yu YB; Chen CY; Pan CC; Lee TS
J Cell Physiol; 2011 Dec; 226(12):3330-9. PubMed ID: 21321940
[TBL] [Abstract][Full Text] [Related]
12. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model.
Ruscher K; Freyer D; Karsch M; Isaev N; Megow D; Sawitzki B; Priller J; Dirnagl U; Meisel A
J Neurosci; 2002 Dec; 22(23):10291-301. PubMed ID: 12451129
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin and normal brain development: receptor expression determines multi-tissue response.
Chen ZY; Warin R; Noguchi CT
Neurodegener Dis; 2006; 3(1-2):68-75. PubMed ID: 16909040
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin enhances mitochondrial biogenesis in cardiomyocytes exposed to chronic hypoxia through Akt/eNOS signalling pathway.
Qin C; Zhou S; Xiao Y; Chen L
Cell Biol Int; 2014 Mar; 38(3):335-42. PubMed ID: 24436050
[TBL] [Abstract][Full Text] [Related]
16. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin protects pancreatic β-cell line NIT-1 cells against cytokine-induced apoptosis via phosphatidylinositol 3-kinase/Akt signaling.
Shuai H; Zhang J; Zhang J; Xie J; Zhang M; Yu Y; Zhang L
Endocr Res; 2011; 36(1):25-34. PubMed ID: 21226565
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
Sakamoto H; Kitamura T; Yoshimura A
J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
[TBL] [Abstract][Full Text] [Related]
19. Acute erythropoietin cardioprotection is mediated by endothelial response.
Teng R; Calvert JW; Sibmooh N; Piknova B; Suzuki N; Sun J; Martinez K; Yamamoto M; Schechter AN; Lefer DJ; Noguchi CT
Basic Res Cardiol; 2011 May; 106(3):343-54. PubMed ID: 21347618
[TBL] [Abstract][Full Text] [Related]
20. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.
Sasaki A; Yasukawa H; Shouda T; Kitamura T; Dikic I; Yoshimura A
J Biol Chem; 2000 Sep; 275(38):29338-47. PubMed ID: 10882725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
